Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Globus Medical Inc (NY: GMED )

68.06 +0.65 (+0.96%)
Official Closing Price Updated: 4:10 PM EDT, Jun 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Globus Medical Inc

< Previous 1 2 3 4 5 Next >
7 Healthcare Stocks Taking Medicine to the Next Level
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider. 
Via InvestorPlace
The Analyst Verdict: Globus Medical In The Eyes Of 6 Experts
Via Benzinga
NYSE:GMED qualifies as a high growth stock and is consolidating.
GLOBUS MEDICAL INC - A (NYSE:GMED)—A High-Growth Stock Gearing Up for Its Next Upward Move. 
Via Chartmill
Investors seeking growth at a reasonable cost should explore NYSE:GMED.
In the world of growth stocks, NYSE:GMED shines as a value proposition. 
Via Chartmill
Assessing Globus Medical: Insights From 5 Financial Analysts
Via Benzinga
3 Stocks at the Forefront of Medical Robotics
Although the concept of medical robotics stocks is incredibly risky, the sector also offers tremendous upside for the intrepid. 
Via InvestorPlace
NYSE:GMED: a strong growth stock preparing for the next leg up?.
GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock and is consolidating. 
Via Chartmill
Expert Ratings for Globus Medical
Via Benzinga
Globus Medical: Q3 Earnings Insights
Via Benzinga
NYSE:GMED is showing good growth, while it is not too expensive.
NYSE:GMED, a growth stock which is not overvalued. 
Via Chartmill
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
GLOBUS MEDICAL INC - A (NYSE:GMED) is not too expensive for the growth it is showing. 
Via Chartmill
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
Despite its growth, NYSE:GMED remains within the realm of affordability. 
Via Chartmill
Globus Medical (GMED) Q3 2023 Earnings Call Transcript
GMED earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
Via Benzinga
What 8 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
The Latest Analyst Ratings for Globus Medical
Via Benzinga
Where Globus Medical Stands With Analysts
Via Benzinga
Globus Medical's Untapped Potential Beyond The NUVA Transaction; Analyst Turns Bullish
Stifel analyst Mathew Blackman upgraded Globus Medical, Inc. (NYSE: GMED) to Buy from Hold, 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
Via Benzinga
Globus Medical (GMED) Q2 2023 Earnings Call Transcript
GMED earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Expert Ratings for Globus Medical
Via Benzinga
Analyst Expectations for Globus Medical's Future
Via Benzinga
Globus Medical (GMED) Q1 2023 Earnings Call Transcript
GMED earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Globus Medical: Q1 Earnings Insights
Via Benzinga
What 8 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
7 Stocks to Buy with Bulletproof Balance Sheets
If you believe a recession is coming – and that’s what the data suggest – you should consider these stocks with strong balance sheets. 
Via InvestorPlace
Minimally Invasive Surgery — This Company's Successful Trial Could Help Eliminate The Need For An Incision In Patients With Back Pain
As medical technology progresses, the world’s approach to surgical operations is also advancing and changing significantly. As part of this, minimally invasive surgery (MIS), in recent years, has taken... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
Via Benzinga
Inflation, TikTok, and Other Hot Stories Investors Are Talking About
We've also got the latest in automotive, homebuilding, and the war on cash. 
Via The Motley Fool
Top 5 Health Care Stocks That May Rocket Higher In Q1 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.